National Heart, Lung, and Blood Institute; Notice of Meeting, 33185 [05-11218]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 108 / Tuesday, June 7, 2005 / Notices
Licensing Contact: Susan Ano; 301/
435–5515; anos@mail.nih.gov.
This technology describes retroviruslike particles and their production from
retroviral constructs in which the gene
encoding all but seven amino acids of
the nucleocapsid (NC) protein was
deleted. This deletion functionally
eliminates packaging of the genomic
RNA, thus resulting in non-infectious
retrovirus-like particles. These particles
can be used in vaccines or immunogenic
compositions. Specific examples using
HIV–1 constructs are given.
Furthermore, efficient formation of
these particles requires inhibition of the
protease enzymatic activity, either by
mutation to the protease gene in the
construct or by protease inhibitor
thereby ensuring the production of noninfectious retrovirus-like particles. This
technology is further described in Ott et
al., Journal of Virology, 2003, 77(5),
5547.
Dated: May 26, 2005.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology
Transfer,National Institutes of Health.
[FR Doc. 05–11221 Filed 6–6–05; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Heart, Lung, and Blood
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in secions 552b(c)(4)
and 552b(c)(6), title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate jul<14>2003
20:54 Jun 06, 2005
Jkt 205001
Name of Committee: National Heart, Lung,
and Blood Advisory Council.
Date: June 16, 2005.
Open: 8:30 a.m. to 1 p.m.
Agenda: Discussion of program policies
and issues.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892.
Closed: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892.
Contact Person: Deborah P. Beebe, PhD,
Director, Division of Extramural Affairs,
National Heart, Lung, and Blood Institute,
National Institutes of Health, Two Rockledge
Center, Room 7100, 6701 Rockledge Drive,
Bethesda, MD 20892. 301/435–0260.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into the building by non-government
employees. Persons without a government
I.D. will need to show a photo I.D. and signin at the security desk upon entering the
building.
Information is also available on the
Institute’s/Center’s home page https://
www.nhlbi.nih.gov/meetings/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS.)
Dated: May 31, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–11218 Filed 6–6–05; 8:45 am]
BILLING CODE 4410–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the Neurological
Sciences and Disorders C, June 14, 2005,
8 a.m. to June 15, 2005, 5 p.m.
Wyndham Washington, DC 1400 M
PO 00000
Frm 00131
Fmt 4703
Sfmt 4703
33185
Street, NW., Washington, DC 20005
which was published in the Federal
Register on April 27, 2005, 70 FR Doc:
05–8413.
The meeting will be held for one day
on June 14, 2005 from 8 a.m. to 5 p.m.
The meeting is closed to the public.
Dated: May 27, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–11222 Filed 6–6–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of persoanl privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, 05–84, Review K22.
Date: June 30, 2005.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Soheyla Saadi, PhD,
Scientific Review Administrator, Intern,
Scientific Review Branch, 45 Center Dr. Rm
4AN32A, National Inst of Dental &
Craniofacial Research, National Institutes of
Health, Bethesda, MD 20892, (301) 594–4805,
saadisoh@nidcr.nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, 05–79, Review R13s.
Date: July 6, 2005.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Mary Kelly, Scientific
Review Specialist, National Institute of
E:\FR\FM\07JNN1.SGM
07JNN1
]]>Agencies
[Federal Register Volume 70, Number 108 (Tuesday, June 7, 2005)]
[Notices]
[Page 33185]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-11218]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Heart, Lung, and Blood Advisory Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in secions 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Advisory
Council.
Date: June 16, 2005.
Open: 8:30 a.m. to 1 p.m.
Agenda: Discussion of program policies and issues.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Bethesda, MD 20892.
Closed: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Deborah P. Beebe, PhD, Director, Division of
Extramural Affairs, National Heart, Lung, and Blood Institute,
National Institutes of Health, Two Rockledge Center, Room 7100, 6701
Rockledge Drive, Bethesda, MD 20892. 301/435-0260.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance into the building by non-government
employees. Persons without a government I.D. will need to show a
photo I.D. and sign-in at the security desk upon entering the
building.
Information is also available on the Institute's/Center's home
page https://www.nhlbi.nih.gov/meetings/index.htm, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS.)
Dated: May 31, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-11218 Filed 6-6-05; 8:45 am]
BILLING CODE 4410-01-M
